APRIL and TACI interact with syndecan‐1 on the surface of multiple myeloma cells to form an essential survival loop
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BLyS and APRIL share two receptors – transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and B‐cell maturation antigen (BCMA) – and BLyS binds to a third receptor, BAFF‐R. We previously reported that TACI gene expression is a good indicator of a BLyS‐binding receptor in human multiple myeloma cell lines (HMCLs), unlike BCMA, which is expressed by all HMCLs or BAFF‐R which is typically not expressed by late‐stage B cells. We hypothesised a link between APRIL and TACI through syndecan‐1, similar to the situation reported for FGF and FGFR. We observed very strong binding of APRIL, but not BLyS, at the surface of all syndecan‐1+ HMCLs and primary multiple myeloma cells (MMC). All syndecan‐1+ HMCLs and MMC could also bind TACI‐Fc, but not BCMA‐Fc or BAFF‐R‐Fc molecules. Binding of APRIL or TACI‐Fc was abrogated by heparin or cell pretreatment with heparitinase, which cleaves heparan sulfate chains. The growth factor activity of APRIL on MMC was also inhibited by heparin. Our data identify syndecan‐1 as a co‐receptor for APRIL and TACI at the cell surface of MMC, promoting the activation of an APRIL/TACI pathway that induces survival and proliferation in MMC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983 · cited 1×
“In addition, Keats et al reported that DEX was poorly efficient compared to bortezomib in patients with NF-κB alterations whereas both therapies were efficient in other patients[25].”
BackgroundAnnunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Moreaux, J., Legouffe, E., Jourdan, E., Quittet, P., Rème, T., Lugagne, C., Moine, P., Rossi, J.-F., Klein, B., & Tarte, K. (2004) · Blood · doi:10.1182/blood-2003-06-1984 · Cited by 558 · cited 8×
“factors for MMC not only in an in vitro (12, 13) but also in an in vivo murine model (17).”
BackgroundResultInfluentialSelf-citationDerksen, P. W. B., Keehnen, R. M. J., Evers, L. M., van Oers, M. H. J., Spaargaren, M., & Pals, S. T. (2002) · Blood · doi:10.1182/blood.v99.4.1405 · Cited by 274
Mahtouk, K., Cremer, F. W., Rème, T., Jourdan, M., Baudard, M., Moreaux, J., Requirand, G., Fiol, G., De Vos, J., Moos, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209699 · Cited by 105 · cited 1×
“Therefore, we speculate that MMC can bind several hundred thousand APRIL molecules through syndecan-1 as this was estimated previously for amphiregulin or HBEGF binding to MMC (42).”
BackgroundSelf-citation
Cited by
The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
Vincent, F. B., Saulep-Easton, D., Figgett, W. A., Fairfax, K. A., & Mackay, F. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.04.003 · Cited by 445
Tai, Y.-T., Acharya, C., An, G., Moschetta, M., Zhong, M. Y., Feng, X., Cea, M., Cagnetta, A., Wen, K., van Eenennaam, H., et al. (2016) · Blood · doi:10.1182/blood-2016-01-691162 · Cited by 350
Seckinger, A., Delgado, J. A., Moser, S., Moreno, L., Neuber, B., Grab, A., Lipp, S., Merino, J., Prosper, F., Emde, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.002 · Cited by 312
Cho, S.-F., Anderson, K. C., & Tai, Y.-T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01821 · Cited by 294
Caraux, A., Klein, B., Paiva, B., Bret, C., Schmitz, A., Fuhler, G. M., Bos, N. A., Johnsen, H. E., Orfao, A., Perez-Andres, M., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.018689 · Cited by 255
Self-citation
Metadata
- Authors
- Moreaux, J., Sprynski, A., Dillon, S. R., Mahtouk, K., Jourdan, M., Ythier, A., Moine, P., Robert, N., Jourdan, E., Rossi, J. F., & Klein, B.
- Venue
- European Journal of Haematology
- Publisher
- Wiley
- Published
- 2009-07-02
- Volume
- 83
- Issue
- 2
- Pages
- 119-129
- ISSN
- 0902-4441 (ISSN-L)
- 1600-0609
- OpenAlex
- W2017328208
- Cited by
- 119
- References
- 5
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: APRIL and TACI interact with syndecan‐1 on the surface of multiple myeloma cells to form an essential survival loop. https://app.cochat.ai/papers/10.1111/j.1600-0609.2009.01262.x
- The paper
- Moreaux, J., Sprynski, A., Dillon, S. R., Mahtouk, K., Jourdan, M., Ythier, A., Moine, P., Robert, N., Jourdan, E., Rossi, J. F., & Klein, B. (2009). APRIL and TACI interact with syndecan‐1 on the surface of multiple myeloma cells to form an essential survival loop. European Journal of Haematology. https://doi.org/10.1111/j.1600-0609.2009.01262.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.